CELZ logo
CELZ NASDAQ US

Creative Medical Technology Holdings, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO May 2009
$2.05
▲ +$0.06 (+3.19%)
Vol 4K
3
Quality Score
fail
Mkt Cap
$5.1M
ROE
-88.9%
Margin
-36070.7%
D/E
0.00
Beta
2.17
52W
$2–$7

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

APRE
Aprea Therapeutics Inc
$6.0M
GRDX
GridAI Technologies Corp
RNAZ
Transcode Therapeutics Inc
$6.3M
PMCB
PharmaCyte Biotech Inc
$7.3M
SYBX
Synlogic Inc
$13.1M
LIMN
Liminatus Pharma Inc
$16.5M
TCRT
Alaunos Therapeutics Inc
$7.2M
XBIO
Xenetic Biosciences Inc
$5.0M

Earnings

Beat rate: 50.0%
Next Report May 07, 2026
Quarter EPS Est EPS Act Surprise
Mar 2026 — — —
Sep 2025 $-0.49 $-0.48 +$0.01
Jun 2025 $-0.64 $-0.48 +$0.16
Mar 2025 $-0.53 $-0.83 $-0.30

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -83.0% -83.0% -83.0% -83.0% -83.0% -88.9%
P/E (TTM) — — — — — —
Net Margin — -36070.7% -36070.7% -36070.7% -36070.7% -36070.7%
Gross Margin — 60.0% 60.0% 60.0% 60.0% 60.0%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 23.89 23.89 23.89 23.89 23.89 20.71

Key Ratios

ROA (TTM)
-85.2%
P/S (TTM)
361.27
P/B
0.6
EPS (TTM)
$-2.87
CF/Share
$-6.88
Rev Growth 3Y
-50.4%
52W High
$6.90
52W Low
$1.69
$1.69 52-Week Range $6.90

How does CELZ compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

CELZ AAPG ABEO ABOS ABP

CELZ valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
361.3
▲ 2711% above peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.6
▼ 74% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

CELZ profitability vs Biotechnology peers

ROE
-88.9%
▼ 32% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-36070.7%
▼ 12479% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
60.0%
▼ 24% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-85.2%
▼ 82% below peers (-46.7%)
vs Peers
vs Industry
Weak

CELZ financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
20.7
▲ 366% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.2
▲ 124% above peers (1.0)
vs Peers
vs Industry
More volatile

CELZ fundamentals radar

CELZ Peer median Industry

CELZ profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

CELZ vs peers: key metrics

Latest News

No related news yet